Sign up
Healthed-White-on-Blue

Clinical case: Tirzepatide dose reduction and the impact on long-term maintenance of weight loss

Description

In this Quick Case, Endocrinologist A/Prof Samantha Hocking outlines evidence from the SURMOUNT-MAINTAIN study, demonstrating how tirzepatide dose reduction or elimination impacts the maintenance of weight loss, cardiometabolic benefits, and clinical decision-making in obesity management (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ralph Audehm & Prof Jeremy Grummet

A/Prof Ralph Audehm & Prof Jeremy Grummet

New Prostate Cancer Screening Guidelines – Case-Based Explanation for GP

Dr Katherine Spira

Dr Katherine Spira

Acute Migraine Management

A/Prof Gary Kilov AM

A/Prof Gary Kilov AM

Continuous Glucose Monitoring Update – Why it will Soon Become Standard Care

Dr Aviv Pudipeddi & Dr David Lim

Dr Aviv Pudipeddi & Dr David Lim

Faecal Calprotectin – A Practical Guide to the Test and the New Item Number

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

01 September 2026
Register Now
A/Prof Samantha Hocking

expert

A/Prof Samantha Hocking

Endocrinologist; Royal Prince Alfred Hospital; Clinical Academic at Charles Perkins Research Centre, University of Sydney; President, National Association of Clinical Obesity Services (NACOS)

Date published: 17 July 2026

Discover

Healthed

CPD platform